As of 3:59pm ET
| -0.01 / -0.08%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 13.75, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +9.91% increase from the last price of 12.51.
The current consensus among 5 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since April, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.